Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

Please provide your email address to receive an email when new articles are posted on . Cryoballoon ablation was noninferior to radiofrequency ablation in patients with atrial fibrillation and HFrEF.

Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...

Please provide your email address to receive an email when new articles are posted on . Improved atrial fibrillation ablation strategies and technologies during the past decade are associated with a ...

The following is an edited version of a talk I gave at HRS. I last wrote about the possibility that atrial fibrillation (AF) ablation exerted a strong placebo effect in 2016. Three years on, the ...

The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Many patients have coexisting coronary artery disease and AF, and either ...